UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in SNDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,526,517
+$27,263 QoQ
Shares Held
161,323
+7.7% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 242 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. SNDX ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in SNDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,526,517 | 161,323 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,499,254 | 149,797 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,991,967 | 142,407 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,065,603 | 134,261 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,398,729 | 256,138 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,465,546 | 200,696 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,248,721 | 170,100 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,645,853 | 137,447 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,148,479 | 153,360 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,304,623 | 96,833 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,011,176 | 93,067 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,113,143 | 76,663 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,123,562 | 53,682 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,133,761 | 53,682 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,478,515 | 58,095 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,040,569 | 43,303 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $889,984 | 46,257 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $675,594 | 38,872 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $850,907 | 38,872 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $742,843 | 38,872 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $732,677 | 42,672 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $858,333 | 38,387 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $582,688 | 26,200 | Shares | Sole | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||